
Cephalexin is a first-generation cephalosporin antibiotic used in microbiology research to study the inhibition of peptidoglycan synthesis and the management of Gram-positive bacterial infections.
In the field of clinical microbiology and drug resistance, the ability to arrest the final transpeptidation step of peptidoglycan synthesis is a major advantage. Cephalexin is specifically selected because of its broad-spectrum activity against Gram-positive cocci, including Staphylococcus aureus and Streptococcus pneumoniae. For instance, it is used to investigate the treatment of respiratory tract infections and uncomplicated skin structures. Consequently, it facilitates the development of high-efficacy capsules, tablets, and pediatric suspensions with higher efficiency. As a result, Zyntex ensures that our high-purity API maintains strict monohydrate stability and meets global pharmacopoeial standards for potency and crystalline uniformity.
Moreover, the research-grade Cephalexin provided by Zyntex is a vital component in the study of beta-lactamase resistance mechanisms. This application allows for the creation of advanced profiles for enzymatic degradation prevention, undoubtedly pushing the boundaries of what is possible in modern anti-infective therapy. At the same time, its pharmacokinetic profile featuring rapid gastrointestinal absorption is highly valued by global pharmaceutical research organizations. In short, our product serves as a dependable “precision-antibiotic” for companies focusing on both community health and sustainable healthcare infrastructure.
Recently, scientific interest has surged regarding the use of Cephalexin in orthopedic prophylactic research. Because of this, Zyntex offers specialized analytical documentation to provide safer and more convenient validation in various laboratory environments. Ultimately, by choosing Zyntex as your supplier, you secure a reliable supply chain that balances chemical potency with rigorous logistical safety. To conclude, our commitment to chemical excellence ensures that your manufacturing processes—whether in fine chemistry or clinical research—achieve the highest levels of purity and yield.
This high-performance cephalosporin is specifically vital in the following four sectors:
A potent agent for studying MIC (Minimum Inhibitory Concentration); thus enabling the production of high-value susceptibility data.
Key API for first-line oral antibiotics; consequently vital for developing stable clinical formulations.
Used to investigate PBP mutations in resistant strains; undoubtedly essential for identifying new antimicrobial targets.
Used in animal health research for skin and soft tissue infections; specifically helping researchers design species-specific dosages.
| Parameter | Standard Value |
|---|---|
| Product Name | Cephalexin Monohydrate |
| Assay / Purity | 95.0% – 103.0% (Anhydrous Basis) |
| Molecular Formula | C16H17N3O4S · H2O |
| CAS Number | 15686-71-2 |
⚠️ Safety Warning: Cephalexin may cause allergic reactions in individuals sensitive to penicillins or other beta-lactams. Therefore, it must be handled in controlled laboratory environments with adequate ventilation and PPE. Store in a cool, dry place and keep the container tightly closed to prevent hydration changes.
For comprehensive toxicological profiles, material safety data sheets (MSDS), and physical property validation, please refer to the official PubChem entry: Chemical Safety Data – Cephalexin (15686-71-2)